Annual Total Long Term Liabilities
$25.60 M
-$23.85 M-48.24%
31 December 2023
Summary:
EyePoint Pharmaceuticals annual total long term liabilities is currently $25.60 million, with the most recent change of -$23.85 million (-48.24%) on 31 December 2023. During the last 3 years, it has fallen by -$32.69 million (-56.08%). EYPT annual total long term liabilities is now -56.08% below its all-time high of $58.29 million, reached on 31 December 2020.EYPT Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$33.39 M
-$453.00 K-1.34%
30 September 2024
Summary:
EyePoint Pharmaceuticals quarterly total long term liabilities is currently $33.39 million, with the most recent change of -$453.00 thousand (-1.34%) on 30 September 2024. Over the past year, it has dropped by -$4.14 million (-11.02%). EYPT quarterly long term liabilities is now -42.72% below its all-time high of $58.29 million, reached on 31 December 2020.EYPT Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EYPT Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -48.2% | -11.0% |
| 3 y3 years | -56.1% | -39.9% |
| 5 y5 years | +34.2% | -36.7% |
EYPT Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -56.1% | at low | -39.9% | +99.5% |
| 5 y | 5 years | -56.1% | +34.2% | -42.7% | +99.5% |
| alltime | all time | -56.1% | -42.7% |
EyePoint Pharmaceuticals Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $33.39 M(-1.3%) |
| June 2024 | - | $33.84 M(+102.2%) |
| Mar 2024 | - | $16.73 M(-34.6%) |
| Dec 2023 | $25.60 M(-48.2%) | $25.60 M(-31.8%) |
| Sept 2023 | - | $37.53 M(-24.2%) |
| June 2023 | - | $49.48 M(+1.1%) |
| Mar 2023 | - | $48.96 M(-1.0%) |
| Dec 2022 | $49.45 M(-10.6%) | $49.45 M(-0.9%) |
| Sept 2022 | - | $49.88 M(+2.5%) |
| June 2022 | - | $48.68 M(+6.4%) |
| Mar 2022 | - | $45.77 M(-17.3%) |
| Dec 2021 | $55.33 M(-5.1%) | $55.33 M(-0.4%) |
| Sept 2021 | - | $55.57 M(-0.2%) |
| June 2021 | - | $55.71 M(-3.9%) |
| Mar 2021 | - | $57.99 M(-0.5%) |
| Dec 2020 | $58.29 M(+9.7%) | $58.29 M(+3.6%) |
| Sept 2020 | - | $56.27 M(+0.6%) |
| June 2020 | - | $55.91 M(+4.5%) |
| Mar 2020 | - | $53.52 M(+0.7%) |
| Dec 2019 | $53.12 M(+178.5%) | $53.12 M(+0.7%) |
| Sept 2019 | - | $52.76 M(+0.7%) |
| June 2019 | - | $52.40 M(+40.4%) |
| Mar 2019 | - | $37.32 M(+99.2%) |
| Dec 2018 | $19.08 M(-50.2%) | - |
| Sept 2018 | - | $18.73 M(-51.1%) |
| June 2018 | $38.32 M(>+9900.0%) | $38.32 M(+84.7%) |
| Mar 2018 | - | $20.75 M(>+9900.0%) |
| Dec 2017 | - | $42.00 K(-10.6%) |
| Sept 2017 | - | $47.00 K(-7.8%) |
| June 2017 | $51.00 K(-99.1%) | $51.00 K(-7.3%) |
| Mar 2017 | - | $55.00 K(-3.5%) |
| Dec 2016 | - | $57.00 K(-99.0%) |
| Sept 2016 | - | $5.64 M(-0.0%) |
| June 2016 | $5.64 M(-0.1%) | $5.64 M(+0.0%) |
| Mar 2016 | - | $5.64 M(+0.0%) |
| Dec 2015 | - | $5.64 M(-0.0%) |
| Sept 2015 | - | $5.64 M(-0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2015 | $5.65 M(+0.5%) | $5.65 M(+0.2%) |
| Mar 2015 | - | $5.64 M(+0.1%) |
| Dec 2014 | - | $5.63 M(+0.1%) |
| Sept 2014 | - | $5.63 M(+0.1%) |
| June 2014 | $5.62 M(+7.1%) | $5.62 M(+4.1%) |
| Mar 2014 | - | $5.40 M(-11.0%) |
| Dec 2013 | - | $6.07 M(+7.6%) |
| Sept 2013 | - | $5.64 M(+7.5%) |
| June 2013 | $5.25 M(+38.7%) | $5.25 M(+1.0%) |
| Mar 2013 | - | $5.19 M(+0.9%) |
| Dec 2012 | - | $5.15 M(+38.6%) |
| Sept 2012 | - | $3.71 M(-1.8%) |
| June 2012 | $3.78 M(-18.6%) | $3.78 M(-19.3%) |
| Mar 2012 | - | $4.69 M(+3.7%) |
| Dec 2011 | - | $4.52 M(+15.5%) |
| Sept 2011 | - | $3.92 M(-15.8%) |
| June 2011 | $4.65 M(-34.0%) | $4.65 M(-45.0%) |
| Mar 2011 | - | $8.45 M(+11.7%) |
| Sept 2010 | - | $7.57 M(+7.6%) |
| June 2010 | $7.04 M(+45.3%) | $7.04 M(+7.3%) |
| Mar 2010 | - | $6.56 M(+6.8%) |
| Dec 2009 | - | $6.14 M(+8.5%) |
| Sept 2009 | - | $5.66 M(+16.9%) |
| June 2009 | $4.84 M(-42.5%) | $4.84 M(+13.5%) |
| Mar 2009 | - | $4.27 M(-1.5%) |
| Dec 2008 | - | $4.33 M(-31.1%) |
| Sept 2008 | - | $6.29 M(-25.4%) |
| June 2008 | $8.43 M(+283.4%) | $8.43 M(-22.0%) |
| Mar 2008 | - | $10.81 M(+498.7%) |
| Dec 2007 | - | $1.80 M(-6.1%) |
| Sept 2007 | - | $1.92 M(-12.6%) |
| June 2007 | $2.20 M(-91.9%) | $2.20 M(-70.7%) |
| Dec 2006 | - | $7.51 M(-72.3%) |
| June 2006 | $27.09 M(+252.5%) | $27.09 M(+252.5%) |
| June 2005 | $7.69 M(>+9900.0%) | $7.69 M(>+9900.0%) |
| June 2004 | $0.00(0.0%) | $0.00(0.0%) |
| June 2003 | $0.00(0.0%) | $0.00 |
| June 2001 | $0.00 | - |
FAQ
- What is EyePoint Pharmaceuticals annual total long term liabilities?
- What is the all time high annual total long term liabilities for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals annual total long term liabilities year-on-year change?
- What is EyePoint Pharmaceuticals quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for EyePoint Pharmaceuticals?
- What is EyePoint Pharmaceuticals quarterly long term liabilities year-on-year change?
What is EyePoint Pharmaceuticals annual total long term liabilities?
The current annual total long term liabilities of EYPT is $25.60 M
What is the all time high annual total long term liabilities for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high annual total long term liabilities is $58.29 M
What is EyePoint Pharmaceuticals annual total long term liabilities year-on-year change?
Over the past year, EYPT annual total long term liabilities has changed by -$23.85 M (-48.24%)
What is EyePoint Pharmaceuticals quarterly total long term liabilities?
The current quarterly long term liabilities of EYPT is $33.39 M
What is the all time high quarterly long term liabilities for EyePoint Pharmaceuticals?
EyePoint Pharmaceuticals all-time high quarterly total long term liabilities is $58.29 M
What is EyePoint Pharmaceuticals quarterly long term liabilities year-on-year change?
Over the past year, EYPT quarterly total long term liabilities has changed by -$4.14 M (-11.02%)